ANONYMOUS: "Clinical Trial: RHAPSODY Phase 3 Study to Assess the Efficacy and Safety of Rilonacept Treatment in Subjects With Recurrent Pericarditis", 9 November 2018 (2018-11-09), XP055526507, Retrieved from the Internet <URL:https://clinicaltrials.gov/ct2/show/NCT03737110> [retrieved on 20181123] (B1)

ANONYMOUS: "Utilisation des anti-IL1 dans la PR", 1 December 2012 (2012-12-01), XP055525909, Retrieved from the Internet <URL:http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/antiIL1/F15A_ANTI-IL1.pdf> [retrieved on 20181122] (B1)

ANTONIO BRUCATO ET AL: "Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence : The AIRTRIP Randomized Clinical Trial", JAMA THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, vol. 316, no. 18, 8 November 2016 (2016-11-08), US, pages 1906, XP055526374, ISSN: 0098-7484, DOI: 10.1001/jama.2016.15826 (B1)

APOSTOLOS KONTZIAS: "Anakinra: A Promising Therapy For Refractory Idiopathic Recurrent Pericarditis", 9 December 2015 (2015-12-09), XP055526152, Retrieved from the Internet <URL:https://www.acc.org/latest-in-cardiology/articles/2015/12/09/12/19/anakinra-a-promising-therapy-for-refractory-idiopathic-recurrent-pericarditis> [retrieved on 20181122] (B1)

BENJAMIN W. VAN TASSELL ET AL: "Targeting Interleukin-1 in Heart Disease", CIRCULATION, vol. 128, no. 17, 22 October 2013 (2013-10-22), US, pages 1910 - 1923, XP055526309, ISSN: 0009-7322, DOI: 10.1161/CIRCULATIONAHA.113.003199 (B1)

BRUCATO ANTONIO ET AL: "Pathogenetic mechanisms, new drugs, and old problems in idiopathic recurrent pericarditis: Comment on the article by Picco et al. + Reply", ARTHRITIS & RHEUMATISM, vol. 60, no. 8, 1 August 2009 (2009-08-01), US, pages 2543 - 2544, XP093047605, ISSN: 0004-3591, DOI: 10.1002/art.24755 (B1)

US-A1- 2006 171 948 (B1)

EISENBERG R ET AL: "Management of refractory recurrent pericarditis and Familial Mediterranean Fever (FMF) related attacks with IVIG and interleukin 1 inhibition", WORLD ALLERGY ORGANIZATION JOURNAL, vol. 10, no. Suppl. 1, 9 December 2016 (2016-12-09), XP002809311 (B1)

FERNÁNDEZ-RUIZ IRENE: "The IL-1 trap rilonacept resolves and prevents recurrent pericarditis", NATURE REVIEWS CARDIOLOGY, vol. 18, no. 2, February 2021 (2021-02-01), pages 73, XP037340857, ISSN: 1759-5002, DOI: 10.1038/S41569-020-00491-3 (B1)

GEORGE LAZAROS ET AL: "The Therapeutic Role of Interleukin-1 Inhibition in Idiopathic Recurrent Pericarditis: Current Evidence and Future Challenges", FRONTIERS IN MEDICINE, vol. 4, 12 June 2017 (2017-06-12), XP055525908, DOI: 10.3389/fmed.2017.00078 (B1)

IRINA JARA CALABUIG ET AL: "Recurrent Pericarditis as the Presenting Form of Adult Still's Disease", REVISTA ESPANOLA DE CARDIOLOGIA, vol. 70, no. 3, 1 March 2017 (2017-03-01), ES, pages 208 - 209, XP055526477, ISSN: 1885-5857, DOI: 10.1016/j.rec.2016.06.016 (B1)

MARIA JAWORSKA-WILCZYNSKA ET AL: "Post-cardiac injury syndrome", POLISH JOURNAL OF CARDIO-THORACIC SURGERY, vol. 1, 1 January 2013 (2013-01-01), pages 20 - 26, XP055526442, ISSN: 1731-5530, DOI: 10.5114/kitp.2013.34299 (B1)

NORMAN T ILOWITE ET AL: "Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis", ARTHRITIS & RHEUMATOLOGY, JOHN WILEY & SONS, INC, US, vol. 66, no. 9, 26 August 2014 (2014-08-26), pages 2570 - 2579, XP072274015, ISSN: 2326-5191, DOI: 10.1002/ART.38699 (B1)

DEH-MING CHANG ET AL: "Dual biological functions of an interleukin-1 receptor antagonist-interleukin-10 fusion protein and its suppressive effects on joint inflammation", IMMUNOLOGY, vol. 112, no. 4, 1 August 2004 (2004-08-01), pages 643 - 650, XP055014940, ISSN: 0019-2805, DOI: 10.1111/j.1365-2567.2004.01910.x (B1)